VENROCK ENTREPRENEURS FUND IV L P's Net Worth
$20.2 Million
Who is VENROCK ENTREPRENEURS FUND IV L P?
VENROCK ENTREPRENEURS FUND IV L P has an estimated net worth of $20.2 Million. This is based on reported shares across multiple companies, which include QUANTENNA COMMUNICATIONS INC, Anacor Pharmaceuticals, Inc., Bellerophon Therapeutics, Inc., ALIMERA SCIENCES INC, ACCELERON PHARMA INC, and Achaogen Inc.
SEC CIK
VENROCK ENTREPRENEURS FUND IV L P's CIK is 0001277994
Past Insider Trading and Trends
2018 was VENROCK ENTREPRENEURS FUND IV L P's most active year for acquiring shares with 12 total transactions. VENROCK ENTREPRENEURS FUND IV L P's most active month to acquire stocks was the month of October. 2016 was VENROCK ENTREPRENEURS FUND IV L P's most active year for disposing of shares, totalling 7 transactions. VENROCK ENTREPRENEURS FUND IV L P's most active month to dispose stocks was the month of October. 2010 saw VENROCK ENTREPRENEURS FUND IV L P paying a total of $6,366,781.00 for 6,574,605 shares, this is the most they've acquired in one year. In 2013 VENROCK ENTREPRENEURS FUND IV L P cashed out on 150,000 shares for a total of $2,109,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
QUANTENNA COMMUNICATIONS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.65M |
—
|
—
| 2.65M |
Nov 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Anacor Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.03% | -150.00K |
$14.06 | -$2,109,000.00 | 3.58M |
Nov 15
| |||
Form 4
| -0.51% | -19.27K |
$6.30 | -$121,456.52 | 3.73M |
Sep 20
| |||
Form 4
| -0.93% | -35.00K |
$6.51 | -$227,804.50 | 3.74M |
Sep 14
| |||
Form 4
| -0.66% | -25.18K |
$6.59 | -$165,932.26 | 3.78M |
Sep 11 - Sep 13
| |||
Form 4
| -17.74% | -820.55K |
—
|
—
| 3.8M |
Jul 2
| |||
Form 4
|
∞
| 2.63M |
$5.00 |
—
| 2.63M |
Nov 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Bellerophon Therapeutics, Inc. (BLPH) Snapshot price: $0.064
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -14.53% | -1.09M |
$0.48 | -$524,957.25 | 6.44M |
Oct 24 - Oct 28
| |||
Form 4
| +1.93% | 142.86K |
$0.70 | $99,999.90 | 7.53M |
Jan 23
| |||
Form 4
| +2.93% | 210K |
$1.20 | $252,354.00 | 7.39M |
Sep 13 - Sep 17
| |||
Form 4
| +7.09% | 475K |
$1.18 | $558,392.50 | 7.18M |
Sep 10 - Sep 12
| |||
Form 4
| +2.45% | 160K |
$0.86 | $138,162.00 | 6.7M |
Sep 5 - Sep 7
| |||
Form 4
| +8.81% | 529.37K |
$0.65 | $342,879.06 | 6.54M |
Aug 14 - Aug 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ALIMERA SCIENCES INC (ALIM) Snapshot price: $3.93
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -11.90% | -838.71K |
—
|
—
| 6.21M |
May 6
| |||
Form 4
|
∞
| 3.95M |
$11.00 |
—
| 3.95M |
Apr 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ACCELERON PHARMA INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |